10x Genomics Inc (TXG) saw its stock price soar 16.79% during intraday trading on Friday, reflecting strong investor sentiment.
The significant price movement follows a series of positive analyst actions, with multiple financial institutions raising their target prices for the genomics company. Deutsche Bank increased its target to $17 from $16, JP Morgan raised to $17 from $15, Jefferies lifted to $21 from $17, Stifel boosted to $20 from $15, and TD Cowen moved to $19 from $18.
These coordinated analyst upgrades suggest growing optimism about 10x Genomics' business prospects and future performance, driving increased buying activity during the trading session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.